Related Experiment Video
Updated: Jul 2, 2026
07:54
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
[Ovarian carcinoma. Do the subtypes reflect different diseases?]
1Department of Pathology Genetic Pathology Evaluation Centre, Vancouver General Hospital and the University of British Columbia, West 10th Avenue, V5Z 4E3 Vancouver, BC, Canada. martin.koebel@vch.ca
Der Pathologe
|August 19, 2008
Summary
Ovarian carcinomas are often treated as one disease, but subtypes like serous and endometrioid can be identified. Reproducible subtype classification improves patient survival stratification for ovarian cancer.
Area of Science:
- Gynecologic Oncology
- Pathology
- Cancer Subtyping
Context:
- Ovarian carcinomas are currently treated as a monolithic entity due to lack of therapeutic options and poor subtype reproducibility.
- Histopathological grading is used to determine the need for adjuvant therapy in ovarian cancer patients.
Purpose:
- To investigate the reproducibility of WHO-based histopathological subtype classification in ovarian carcinomas.
- To determine if reproducible subtype classification can stratify patients based on disease-specific survival.
Summary:
- Modified WHO classification allows reproducible identification of ovarian carcinoma subtypes (serous, endometrioid, clear cell, mucinous).
- These subtypes demonstrate distinct epidemiologic, genetic, molecular, and clinical characteristics.
- Reproducible subtype classification enables accurate stratification of patients according to disease-specific survival.
Impact:
- Highlights the need for subtype-specific screening and management strategies for ovarian cancer.
- Improves prognostic accuracy by moving beyond a monolithic treatment approach.
- Facilitates the development of targeted therapies based on distinct ovarian carcinoma subtypes.
